Celecoxib
Medication Facts
- Performance enhancing
- No
- Total hours to clear
- Not recorded
- Frequently used
- N/A
- ESC ID
- CELECO-0191
- Trade names
- Celebrex
- Drug type
- NSAID (COX-2 inhibitor)
- Plasma half-life · hours
- Not Published
- Equine dosing
- Consult Veterinarian
- Cmax · peak plasma concentration
- N/A Not Permitted
- Tmax · time to peak plasma concentration
- N/A Not Permitted
- ESC concentration guidance
- May not exceed (LDL) Lowest Detectable Level of .05 ng/mL or 50 picograms per mL
- Primary withdrawal · hours
- 48
- Washout withdrawal · hours
- 0
- ESC control type
- A1 - Generally Controlled - Therapeutic
- Medication report required
- Generally not required, however understand exceptions.
Uses & side effects
Product-specific side effects await source review.
Drug interactions
This NSAID, not approved for use in horses. It does not reach therapeuitc values do to its quick half life. High risk for toxicity. Using more than one NSAID concurrently (e.g., combining phenylbutazone, flunixin meglumine, or firocoxib) drastically increases risks of toxicity without increasing pain relief.Corticosteroids (e.g., Dexamethasone): Combining NSAIDs with steroids increases the likelihood of gastric ulcers and severe GI toxicity.Nephrotoxic Agents: Avoid combining NSAIDs with aminoglycoside antibiotics (e.g., gentamicin) or diuretics, as this significantly increases the risk of acute renal failure.Blood Thinners: Concomitant use with anticoagulants (e.g., heparin) increases the risk of bleeding complications.Dehydration/Pre-existing Disease: NSAIDs are more toxic when horses are dehydrated, septic, or have pre-existing kidney or hepatic disease